Screening for Resistance to Activated Protein C and the Mutant Gene for Factor V:Q506 in Patients With Central Retinal Vein Occlusion
- 1 November 1997
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 124 (5) , 673-676
- https://doi.org/10.1016/s0002-9394(14)70905-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- World distribution of factor V LeidenThe Lancet, 1995
- Central Retinal Vein Thrombosis Associated With Resistance to Activated Protein CAmerican Journal of Ophthalmology, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Characterization of the Molecular Defect in Factor VR506APublished by Elsevier ,1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusionsSurvey of Ophthalmology, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993